Bokf, Na Haleon PLC Transaction History

Bokf, Na

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$8.01 - $8.64 $22,764 - $24,554	2,842 Added 68.81%	6,972 $57,000
Q1 2024 May 15, 2024	SELL	$8.02 - $8.67 $10,458 - $11,305	-1,304 Reduced 24.0%	4,130 $35,000
Q4 2023 Feb 14, 2024	SELL	$7.78 - $8.62 $11,825 - $13,102	-1,520 Reduced 21.86%	5,434 $44,000
Q3 2023 Nov 14, 2023	SELL	$7.85 - $8.94 $25,245 - $28,751	-3,216 Reduced 31.62%	6,954 $57,000
Q2 2023 Aug 21, 2023	SELL	$8.04 - $9.0 $7,999 - $8,955	-995 Reduced 8.91%	10,170 $85,000
Q1 2023 May 11, 2023	SELL	$7.57 - $8.37 $119,076 - $131,660	-15,730 Reduced 58.49%	11,165 $90,000
Q4 2022 Feb 13, 2023	SELL	$5.96 - $8.06 $6,961 - $9,414	-1,168 Reduced 4.16%	26,895 $215,000
Q3 2022 Nov 14, 2022	BUY	$5.63 - $7.5 $157,994 - $210,472	28,063 New	28,063 $171,000

638

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $43.4B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.